Dow Operating Cash Flow increased by 295.8% to $1.12B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1135.2%, from $91.00M to $1.12B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -38.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00B | $2.72B | $2.58B | $1.60B | $1.85B | $1.94B | $2.08B | $535.00M | $1.35B | $1.66B | $1.66B | $464.00M | $836.00M | $800.00M | $814.00M | $91.00M | -$470.00M | $1.13B | $284.00M | $1.12B |
| QoQ Change | — | +35.8% | -5.4% | -37.7% | +15.7% | +4.6% | +7.1% | -74.3% | +151.8% | +23.1% | -0.1% | -72.0% | +80.2% | -4.3% | +1.8% | -88.8% | -616.5% | +339.8% | -74.8% | +295.8% |
| YoY Change | — | — | — | — | -7.5% | -28.7% | -19.3% | -66.6% | -27.3% | -14.5% | -20.3% | -13.3% | -37.9% | -51.7% | -50.8% | -80.4% | -156.2% | +40.9% | -65.1% | >999% |